UPDATE: UBS Starts SemGroup (SEMG) at Buy
Tweet
Share
E-mailGet Alerts SEMG Hot Sheet
Price: $25.83 --0%
Rating Summary:
4 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 24
Rating Summary:
4 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 24
Join SI Premium – FREE
(Updated - March 14, 2014 1:40 PM EDT)
UBS initiated coverage on SemGroup (NYSE: SEMG) with a Buy rating and a price target of $74.00.
Analyst Shneur Gershuni said, "SemGroup is a c-corp energy services company with crude and natural gas storage, transportation and marketing services. It is the GP of Rose Rock Midstream Partners and owns a GP and LP interest in NGL Energy Partners. We believe SemGroup is still in the early stages of growth with current organic growth projects underway both at SEMG and RRMS. Additionally 10%+ distribution/unit growth at both RRMS and NGL should drive 20%+ dividend growth."
For an analyst ratings summary and ratings history on SemGroup click here. For more ratings news on SemGroup click here.
Shares of SemGroup closed at $65.14 yesterday.
UBS initiated coverage on SemGroup (NYSE: SEMG) with a Buy rating and a price target of $74.00.
Analyst Shneur Gershuni said, "SemGroup is a c-corp energy services company with crude and natural gas storage, transportation and marketing services. It is the GP of Rose Rock Midstream Partners and owns a GP and LP interest in NGL Energy Partners. We believe SemGroup is still in the early stages of growth with current organic growth projects underway both at SEMG and RRMS. Additionally 10%+ distribution/unit growth at both RRMS and NGL should drive 20%+ dividend growth."
For an analyst ratings summary and ratings history on SemGroup click here. For more ratings news on SemGroup click here.
Shares of SemGroup closed at $65.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Starts Take-Two Interactive (TTWO) at Buy
- Stifel Canada Starts BlackBerry (BB) at Buy
- Cantor Fitzgerald Starts Silence Therapeutics (SLN) at Overweight
Create E-mail Alert Related Categories
Analyst Comments, New CoverageRelated Entities
UBS, Dividend, Crude OilSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
